COVID-19 vaccination offers 60% protection against post-discharge mortality. ICMR study reveals the vaccine's efficacy.
- COVID-19 vaccination provides 60% protection against mortality in the year following hospital discharge
- Males, individuals over 40, and those with comorbidities are at higher risk but still benefit from vaccination
- ICMR's groundbreaking study is among India's first to explore post-hospitalization COVID-19 mortality
Vaccination saves lives: A real-time study of patients with chronic diseases and severe COVID-19
Go to source). The findings, which were part of a study done by the Indian Council of Medical Research and the National Clinical Registry for COVID-19, revealed that the following categories of people were at a higher risk of mortality within a year of discharge:
- Males
- Individuals over the age of 40
- People who already had comorbidities
- People who have a severe or mild infection of COVID-19
ICMR Monitors Long-term Health of Hospitalized COVID-19 Patients
The National Clinical Registry, which the ICMR has been monitoring for COVID-19 across 31 centers, kept in touch with patients who had been hospitalized owing to the virus and recorded regular health status updates for up to one year after release. The study considered data collected up until February 2023.India's Pioneer Study on Post-Hospitalization COVID-19 Mortality
It is the first study in India to look at post-hospitalization mortality in COVID-19 patients. With only a few studies on the vaccine's efficacy to date, the ICMR study adds to the body of knowledge. Earlier this year, renowned virologist Gagandeep Kang said that with COVID-19 variations still emerging regularly, more data was needed.- Vaccination saves lives: A real-time study of patients with chronic diseases and severe COVID-19 - (https://www.icmr.gov.in/pdf/covid/papers/hcac202.pdf)